Jin‐Yong Hwang
YOU?
Author Swipe
View article: Long-term outcomes according to absolute value vs. percentage reduction in low-density lipoprotein cholesterol levels after acute myocardial infarction
Long-term outcomes according to absolute value vs. percentage reduction in low-density lipoprotein cholesterol levels after acute myocardial infarction Open
Backgrounds/aims Real-world data are limited regarding long-term outcomes in terms of absolute follow-up values of low-density lipoprotein cholesterol (LDL-C) vs. percentage reductions from baseline after LDL-C-lowering therapy for patient…
View article: Association and Prognostic Implications of “No-Reflow Phenomenon” and Hypercoagulability in Patients With ST-Segment Elevation Myocardial Infarction
Association and Prognostic Implications of “No-Reflow Phenomenon” and Hypercoagulability in Patients With ST-Segment Elevation Myocardial Infarction Open
This study demonstrated a close relationship between heightened thrombogenicity (assessed by TEG P-FCS) with "no-reflow phenomenon," and their additive prognostic implications after primary PCI in STEMI patients. Effective control of clot …
View article: Prognostic differences between persistent HFrEF and HFrecEF following acute myocardial infarction
Prognostic differences between persistent HFrEF and HFrecEF following acute myocardial infarction Open
Background Acute myocardial infarction (AMI) often leads to heart failure with reduced ejection fraction (HFrEF), with some patients showing recovery of left ventricular ejection fraction (HFrecEF) over time. This study aimed to evaluate t…
View article: Renal hyperfiltration as risk factor of major adverse cardiovascular events in patients with acute myocardial infarction
Renal hyperfiltration as risk factor of major adverse cardiovascular events in patients with acute myocardial infarction Open
View article: Long-term benefit of vasodilating beta-blockers in acute myocardial infarction patients with mildly reduced left ventricular ejection fraction
Long-term benefit of vasodilating beta-blockers in acute myocardial infarction patients with mildly reduced left ventricular ejection fraction Open
Beta-blockers have been considered the cornerstone of treatment for patients with acute myocardial infarction (AMI). However, long-term benefits of vasodilating beta-blockers remain uncertain. This study aimed to investigate the long-term …
View article: Prognostic impact of changes in left ventricular ejection fraction and wall motion score index in patients with myocardial infarction
Prognostic impact of changes in left ventricular ejection fraction and wall motion score index in patients with myocardial infarction Open
Background The prognostic significance of changes in left ventricular ejection fraction (LVEF) and wall motion score index (WMSI) in patients with myocardial infarction remains unclear. Methods This study evaluated whether changes in LVEF …
View article: Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in Older Patients with acute Myocardial Infarction after a Successful Stent Implantation
Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in Older Patients with acute Myocardial Infarction after a Successful Stent Implantation Open
Background: This study aimed to evaluate the long-term clinical outcomes of patients with acute myocardial infarction (AMI) who underwent successful stent implantation and were subsequently treated with angiotensin-converting enzyme inhibi…
View article: Potent P2Y12 inhibitors in patients with acute myocardial infarction and cardiogenic shock
Potent P2Y12 inhibitors in patients with acute myocardial infarction and cardiogenic shock Open
View article: Current Status of Lipid Management and Subsequent Cardiovascular Events After Acute Coronary Syndrome in Korea: Real-World Findings From Observational and Survey Studies
Current Status of Lipid Management and Subsequent Cardiovascular Events After Acute Coronary Syndrome in Korea: Real-World Findings From Observational and Survey Studies Open
View article: Impact of Atrial Fibrillation at the Time of Coronary Revascularization on Long‐Term Outcomes: From the G‐NUH Registry
Impact of Atrial Fibrillation at the Time of Coronary Revascularization on Long‐Term Outcomes: From the G‐NUH Registry Open
Background Coronary artery disease (CAD) and atrial fibrillation (AF) frequently co‐occur. They influence each other in terms of occurrence and aggravation, which has an impact on the prognosis. Meanwhile, there is a lack of reports on whe…
View article: Predictive value and optimal cut-off level of high-sensitivity troponin T in patients with acute pulmonary embolism
Predictive value and optimal cut-off level of high-sensitivity troponin T in patients with acute pulmonary embolism Open
Background/Aims: Elevated troponin levels predict in-hospital mortality and influence decisions regarding thrombolytic therapy in patients with acute pulmonary embolism (PE). However, the usefulness of high-sensitivity troponin T (hsTnT) r…
View article: Optimal timing of revascularization for patients with non-ST segment elevation myocardial infarction and severe left ventricular dysfunction
Optimal timing of revascularization for patients with non-ST segment elevation myocardial infarction and severe left ventricular dysfunction Open
Optimal timing of revascularization for patients who presented with non-ST segment elevation myocardial infarction (NSTEMI) and severe left ventricular (LV) dysfunction is unclear. A total of 386 NSTEMI patients with severe LV dysfunction …
View article: Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study
Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study Open
Statin is crucial for acute myocardial infarction (AMI) patients. However, the risk of new-onset diabetes mellitus (NODM) associated with statin is a concern. This study aimed to determine the incremental diabetogenic effects of statins ac…
View article: Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCC
Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCC Open
Background/Objectives: Self-recognition of recurrent myocardial infarction (re-MI) may be essential for reducing prehospital time contrast to awareness of re-MI symptoms. However, data on the current status and clinical impact of self-reco…
View article: Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial
Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial Open
Introduction There is a lack of evidence to support the effectiveness of prolonged β-blocker therapy after stabilisation of patients with acute myocardial infarction (AMI) without heart failure (HF) or left ventricular systolic dysfunction…
View article: Long-term prognostic implications of brachial-ankle pulse wave velocity in patients undergoing percutaneous coronary intervention
Long-term prognostic implications of brachial-ankle pulse wave velocity in patients undergoing percutaneous coronary intervention Open
Objective The long-term clinical effect of arterial stiffness in high-risk disease entities remains unclear. The prognostic implications of brachial-ankle pulse wave velocity (baPWV) were assessed using a real-world registry that included …
View article: Very early vs delayed invasive strategy in high-risk NSTEMI patients without hemodynamic instability: Insight from the KAMIR-NIH
Very early vs delayed invasive strategy in high-risk NSTEMI patients without hemodynamic instability: Insight from the KAMIR-NIH Open
Background High-risk non-ST-elevation myocardial infarction (NSTEMI) patients’ optimal timing for percutaneous coronary intervention (PCI) is debated despite the recommendation for early invasive revascularization. This study aimed to comp…
View article: Long-term clinical outcomes of image-guided percutaneous coronary intervention in acute myocardial infarction from the Korea Acute Myocardial Infarction Registry
Long-term clinical outcomes of image-guided percutaneous coronary intervention in acute myocardial infarction from the Korea Acute Myocardial Infarction Registry Open
Imaging modalities for percutaneous coronary intervention (PCI), such as intravascular ultrasound (IVUS) or optical coherence tomography (OCT), have increased in the current PCI era. However, their clinical benefits in acute myocardial inf…
View article: Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor
Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor Open
Background In patients undergoing percutaneous coronary intervention (PCI), the use of anti-inflammatory therapy with colchicine is associated with a reduction of recurrent ischemic events. The mechanisms of such findings are not fully elu…
View article: Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial Open
gov. Unique identifier: NCT04626882; and URL: https://cris.nih.go.kr. Unique identifier: KCT0004457.
View article: Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction Open
In patients with NSTEMI who underwent PCI, an initial elevated NT-proBNP concentration was associated with higher risk of MACE at 3 years, driven primarily by higher risks of cardiac death or admission for heart failure. These results sugg…
View article: P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent
P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent Open
Importance P2Y12 inhibitor monotherapy after dual antiplatelet therapy (DAPT; a P2Y12 inhibitor plus aspirin) for a brief duration has recently emerged as an attractive alternative for patients undergoing percutaneous coronary intervention…
View article: Long-term air pollution exposure is associated with higher incidence of ST-elevation myocardial infarction and in-hospital cardiogenic shock
Long-term air pollution exposure is associated with higher incidence of ST-elevation myocardial infarction and in-hospital cardiogenic shock Open
View article: Association of Diabetic Status with Thrombogenicity Indices and its Prognostic Implication in Patients Undergoing Percutaneous Coronary Intervention
Association of Diabetic Status with Thrombogenicity Indices and its Prognostic Implication in Patients Undergoing Percutaneous Coronary Intervention Open
View article: 2024 Korean Society of Myocardial Infarction/National Evidence-Based Healthcare Collaborating Agency Guideline for the Pharmacotherapy of Acute Coronary Syndromes
2024 Korean Society of Myocardial Infarction/National Evidence-Based Healthcare Collaborating Agency Guideline for the Pharmacotherapy of Acute Coronary Syndromes Open
Many countries have published clinical practice guidelines for appropriate clinical decisions, optimal treatment, and improved clinical outcomes in patients with acute coronary syndrome. Developing guidelines that are specifically tailored…
View article: Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting
Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting Open
Background/Introduction High thrombotic risk (HTR) features are associated with higher ischemic rate, which may be mitigated by potent antiplatelet therapy. However, concomitant high bleeding risk (HBR) may be present, making it unclear wh…
View article: 35 A novel therapeutic approach using taurodeoxycholate, a GPCR19R agonist, for atopic dermatitis: a randomized, double-blind, placebo-controlled phase II trial with identification of predictive biomarkers
35 A novel therapeutic approach using taurodeoxycholate, a GPCR19R agonist, for atopic dermatitis: a randomized, double-blind, placebo-controlled phase II trial with identification of predictive biomarkers Open
View article: Low-Dose Aspirin for Primary Prevention of Cardiovascular Events Comparing East Asians With Westerners
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events Comparing East Asians With Westerners Open
View article: Impact of height difference between coronary ostium and location of intracoronary pressure sensor on fractional flow reserve measurements
Impact of height difference between coronary ostium and location of intracoronary pressure sensor on fractional flow reserve measurements Open
Background During fractional flow reserve (FFR) measurements, distal coronary pressure (Pd) can be influenced by hydrostatic pressure changes resulting from the height difference (HD) between the coronary ostium and the location of the dis…
View article: Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial Open
The authors evaluated the efficacy, safety, and characteristics of patients who respond well to standard dose triple combination therapy including chlorthalidone 25 mg with telmisartan 80 mg plus amlodipine 5 mg in hypertensive patients. T…